Bioorganic and Medicinal Chemistry Letters p. 1019 - 1022 (1998)
Update date:2022-08-05
Topics:
Sasaki, Shigeki
Hashimoto, Tomohiro
Obana, Norihiro
Yasuda, Hideyo
Uehara, Yoshimasa
Maeda, Minoru
New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.
View MoreContact:86-15588110016
Address:LINYI CITY,SHANDONG PROVINCE,CHINA
Changzhou Xuanming Chemical Co., Ltd.
Contact:86 0519 85525329
Address:China Town, Xinbei, Changzhou, Jiangsu Room 6019
Yicheng Goto Pharmaceuticals Co.,Ltd.
Contact:+86 710 3423122
Address:5th Floor,East Gate of Building #2,Servo-Industrial Park,1st Qilin Road,Xiangyang,Hubei,China
Contact:86-21-50966856
Address:Building 5,300 Chuanzhan Road,Pudong New District,Shanghai
Hebei DaPeng Pharm & Chem Co., Ltd.
Contact:86-317-7298678,0576-88861898 88861908
Address:West Songmen Village, East Songmen Town, Wuqiao, Cangzhou, Hebei ,China
Doi:10.1021/ic020375g
(2002)Doi:10.1016/S0277-5387(97)00376-8
(1998)Doi:10.1016/S0040-4039(00)72793-6
(1968)Doi:10.1016/S0040-4039(00)71266-4
(1991)Doi:10.1039/j39680002947
(1968)Doi:10.1016/S0957-4166(97)00128-6
(1997)